08/04/2026 07:10
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care

LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KM...

08/04/2026 07:00
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life scien...

08/04/2026 07:00
Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer

Evexta Bio S.A., a precision oncology company, founded by Truffle Capital (founder of Abivax and Carvolix), and focused on the discovery and development of targeted therapies, today announced a clinical collaboration and supply agreement with plans to initiate a Phase 1b study combining its lead investigational compound, rupitasertib, with Roche’s investigational compound giredestrant, a selective estrogen receptor degrader (SERD), for the treatment of ER+, HER2-, ESR1-mutated advanced / metast...

08/04/2026 07:44
Kioxia Showcases Flash Storage Innovations for the AI Era at FMS 2026

Kioxia group, a world leader in memory solutions, will demonstrate how its flash memory and SSD technologies, including the KIOXIA GP1 Series PCIe® 6.0 NVMe™ Super High IOPS SSDs, optimized for GPU direct access, are enabling the next generation of AI infrastructure at FMS: the Future of Memory and Storage, taking place August 4–6 in Santa Clara, California. Through a keynote presentation, executive panel discussions, technical sessions, and technology demonstrations, Kioxia will showcase the i...

08/04/2026 08:00
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities

Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra...

08/04/2026 09:00
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership

WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press relea...

08/04/2026 11:20
Techtronic Industries Delivers Strong First Half Performance

Techtronic Industries Co. Ltd. (“TTI” or the “Group”) (stock code: HK: 0669, ADR symbol: TTNDY), a global cordless power tool, outdoor power equipment and floorcare & cleaning company, is pleased to announce its results for the six-month period ended June 30, 2026. The Group delivered record first half results in 2026, with revenue growing 5.9% to US$8.3 billion. Its two leading brands, MILWAUKEE and RYOBI, both delivered a strong performance in the first half of 2026, growing at a combined...

08/04/2026 12:00
Darwinbox Launches Cortex, Its New AI-Native HCM Platform

Darwinbox, a leading global Human Capital Management platform serving more than 1,400 enterprises and 4.5 million employees worldwide, today announced Darwinbox Cortex™, the AI-Native HCM platform. Darwinbox rebuilt its HCM platform from the ground up for AI. Rather than adding AI features on top of existing software, Cortex embeds intelligence into the core of the platform. It is launching with pilot customers and technology partners including Microsoft, Slack, Glean, and others. For decades...

08/04/2026 12:00
Altasciences Completes Expansion of Research and Development Laboratory in Harleysville, Pennsylvania

Altasciences is excited to share it has expanded the R&D laboratory at its drug product formulation and manufacturing services facility in Harleysville, Pennsylvania, adding approximately 768 square feet of new laboratory space. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804164599/en/From left to right: Nasir Egal (General Manager, CDMO Services); Marie-Hélène Raigneau (Chief Executive Officer); Anuji Abraham (Senior Dire...

08/04/2026 12:00
Thales Builds Cryptographic Security for the Age of AI and Post-Quantum Computing

According to the 2026 Thales Data Threat Report, the threat of Harvest Now, Decrypt Later (HNDL) attacks was the top-cited risk, with 59% of organizations reporting that they are prototyping and evaluating post-quantum cryptography (PQC) algorithms to prepare for the quantum era. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804370240/en/©Thales To help organizations turn this readiness into deployment, Thales, a global leader i...